结外NK/T细胞淋巴瘤治疗进展(4)
[16]LI X,CHENG Y S,ZHANG M Z,et al.Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma[J].J Hematol Oncol,2018,11(1):1-8.[17]SOMASUNDARAM N,LIM J Q,ONG C K,et al.Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)[J].J Hematol Oncol,2019,12(1):28.
[18]NAIRISMGI M L,GERRITSEN E,LI Z M,et al.Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371 ......
您现在查看是摘要页,全文长 3227 字符。